The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Inspection included drug device combinations covering our recent filing in nasal sprays domain
The Tanuku facility will focus on the production of key therapeutic APIs, including Anti-Tussive, Anti-Coagulant (Blood Thinner), Anaesthetic, and Antidepressant molecules
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The plant is expected to enhance regional supply capabilities
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
Subscribe To Our Newsletter & Stay Updated
